Abstract

Overview

The global market for specialty surgical wound care products-which include sealants, glues, absorbable hemostats, and adhesion prevention products-was valued at $3.1 billion in 2012. Growth is being largely driven by the markets of Asia-Pacific and the Rest-of-the-World, where greater product availability, new indications, and underlying market dynamics-such as rising surgical procedure volumes-are helping to offset sluggishness in the U.S. market. While global revenues are expected to reach $4.2 billion in 2018, key trends, such as efforts to limit expensive hospital admissions, shift procedures to outpatient settings, and reduce rates of readmissions, will have decisive effects on the market for these technologies.

Critical Issues Covered in this Report:

• Analysis of the clinical status of key technologies as well as potential new indications and product introductions;
• The competitive landscape for these products in the U.S. and international markets; and
• Market quantities, including procedure volumes, units, revenues per procedure, and detailed segmentation among product categories.

Table Of Contents

Table of Contents

1. EXECUTIVE SUMMARY
• 1.1 The U.S. Market for Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products
• 1.2 The European Market for Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products
• 1.3 The Market for Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products in AP and ROW Countries
• 1.4 Global Supplier Shares
• Exhibit 1-1: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products by Product Type
• Exhibit 1-2: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products by Region
• Exhibit 1-3: The U.S. Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products by Product Type
• Exhibit 1-4: The European Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products by Product Type
• Exhibit 1-5: The AP and ROW Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products by Product Type
• Exhibit 1-6: Global Supplier Shares in 2011 and 2012

2. OVERVIEW
• 2.1 The Wound Healing Process
o 2.1.1 The Inflammatory Phase
o 2.1.2 Proliferative Phase
o 2.1.3 Remodeling Phase
• 2.2 Types of Wound Healing
• 2.3 Products
o 2.3.1 Sutures
o 2.3.2 Staples
o 2.3.3 Tapes
o 2.3.4 Surgical Adhesives
• Exhibit 2-1: The Three Stages of the Wound Healing Process
• Exhibit 2-2: Types of Wound Healing
• Exhibit 2-3: Types of Products Used in Wound Closure

3. SURGICAL SEALANTS, GLUES, ABSORBABLE HEMOSTATS, and ADHESION PREVENTION PRODUCTS
• 3.1 Indications
• 3.2 Product Types
o 3.2.1 Sealants
o 3.2.2 Glues
o 3.2.3 Absorbable Hemostats
o 3.2.4 Adhesion Prevention Products
• 3.3 Companies and Products
• Exhibit 3-1: Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products
• Exhibit 3-2: Leading Indications for Surgical Wound Closure Products
• Exhibit 3-3: Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products in 2013

4. PROCEDURES and MARKET FORECASTS: SURGICAL SEALANTS, GLUES, ABSORBABLE HEMOSTATS, and ADHESION PREVENTION PRODUCTS
• 4.1 The United States: Procedures and Market Forecasts
o 4.1.1 Surgical Sealants in the U.S.: Procedures and Market Forecasts
o 4.1.2 Surgical Glues in the U.S.: Procedures and Market Forecasts
o 4.1.3 Absorbable Hemostats in the U.S.: Procedures and Market Forecasts
o 4.1.4 Adhesion Prevention Products in the U.S.: Procedures and Market Forecasts
o 4.1.5 Supplier Shares
• 4.2 Europe: Procedures and Market Forecasts
o 4.2.1 Surgical Sealants in Europe: Procedures and Market Forecasts
o 4.2.2 Surgical Glues in Europe: Procedures and Market Forecasts
o 4.2.3 Absorbable Hemostats in Europe: Procedures and Market Forecasts
o 4.2.4 Adhesion Prevention Products in Europe: Procedures and Market Forecasts
• 4.3 Asia-Pacific and the Rest-of-the-World: Procedures and Market Forecasts
o 4.3.1 Surgical Sealants in AP and ROW Countries: Procedures and Market Forecasts
o 4.3.2 Surgical Glues in AP and ROW Countries: Procedures and Market Forecasts
o 4.3.3 Absorbable Hemostats in AP and ROW Countries: Procedures and Market Forecasts
o 4.3.4 Adhesion Prevention Products in AP and ROW Countries: Procedures and Market Forecasts
• 4.4 OUS Supplier Shares
• Exhibit 4-1: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products by Product Type
• Exhibit 4-2: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products by Region
• Exhibit 4-3: The U.S. Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products by Product Type
• Exhibit 4-4: Targeted Surgical Caseloads in the U.S. from 2011-2018
• Exhibit 4-5: Factors Influencing the U.S. Market for Surgical Sealants
• Exhibit 4-6: The U.S. Market Forecast for Surgical Sealants from 2011-2018
• Exhibit 4-7: The U.S. Market Forecast for External and Internal Tissue Sealants from 2011-2018
• Exhibit 4-8: Factors Influencing the U.S. Market for Surgical Glues
• Exhibit 4-9: The U.S. Market Forecast for Surgical Glues from 2011-2018
• Exhibit 4-10: The U.S. Market Forecast for Surgical Glues, Approved and Off-Label Uses, from 2011-2018
• Exhibit 4-11: Factors Influencing the U.S. Market for Absorbable Hemostats
• Exhibit 4-12: The U.S. Market Forecast for Absorbable Hemostats from 2011-2018
• Exhibit 4-13: Factors Influencing the U.S. Market for Adhesion Prevention Products
• Exhibit 4-14: The U.S. Market Forecast for Adhesion Prevention Products from 2011-2018
• Exhibit 4-15: U.S. Supplier Shares in 2011 and 2012
• Exhibit 4-16: The European Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products by Product Type
• Exhibit 4-17: Targeted Surgical Caseloads in Europe from 2011-2018
• Exhibit 4-18: Factors Influencing the European Market for Surgical Sealants
• Exhibit 4-19: The European Market Forecast for Surgical Sealants from 2011-2018
• Exhibit 4-20: The European Market Forecast for External and Internal Tissue Sealants from 2011-2018
• Exhibit 4-21: Factors Influencing the European Market for Surgical Glues
• Exhibit 4-22: The European Market Forecast for Surgical Glues from 2011-2018
• Exhibit 4-23: The European Market Forecast for Surgical Glues from 2011-2018: Open Repairs of the Large Vessels and Other Indications
• Exhibit 4-24: Factors Influencing the European Market for Absorbable Hemostats
• Exhibit 4-25: The European Market Forecast for Absorbable Hemostats from 2011-2018
• Exhibit 4-26: Factors Influencing the European Market for Adhesion Prevention Products
• Exhibit 4-27: The European Market Forecast for Adhesion Prevention Products from 2011-2018
• Exhibit 4-28: The AP and ROW Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products by Product Type
• Exhibit 4-29: Targeted Surgical Caseloads in AP and ROW Countries from 2011-2018
• Exhibit 4-30: Factors Influencing the Market for Surgical Sealants in AP and ROW Countries
• Exhibit 4-31: The AP and ROW Market Forecast for Surgical Sealants from 2011-2018
• Exhibit 4-32: The AP and ROW Market Forecast for External and Internal Tissue Sealants from 2011-2018
• Exhibit 4-33: Factors Influencing the Market for Surgical Glues in AP and ROW Countries
• Exhibit 4-34: The AP and ROW Market Forecast for Surgical Glues from 2011-2018
• Exhibit 4-35: The AP and ROW Market Forecast for Surgical Glues from 2011-2018: Open Repairs of the Large Vessels and Other Indications
• Exhibit 4-36: Factors Influencing the Market for Absorbable Hemostats in AP and ROW Countries
• Exhibit 4-37: The AP and ROW Market Forecast for Absorbable Hemostats from 2011-2018
• Exhibit 4-38: Factors Influencing the Market for Adhesion Prevention Products in AP and ROW Countries
• Exhibit 4-39: The AP and ROW Market Forecast for Adhesion Prevention Products from 2011-2018
• Exhibit 4-40: OUS Supplier Shares in 2011 and 2012

5. COMPANY PROFILES
• 5.1 Baxter International
• 5.2 Covidien
• 5.3 CryoLife
• 5.4 CSL Behring
• 5.5 Davol (C.R. Bard)
• 5.6 Ethicon (Johnson and Johnson)
• 5.7 Genzyme (Sanofi-Aventis)
• 5.8 Pfizer
• 5.9 Takeda Pharmaceuticals International
• 5.10 Zymogenetics (Bristol-Myers Squibb)
Companies
• Baxter International
• Covidien
• CryoLife
• CSL Behring
• Davol (C.R. Bard)
• Ethicon (Johnson and Johnson)
• Genzyme (Sanofi-Aventis)
• Pfizer
• Takeda Pharmaceuticals International
• Zymogenetics (Bristol-Myers Squibb)

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.